<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Inhibition of SIRT1/2 upregulates HSPA5 acetylation and induces pro-survival 
autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells.

Sirtuins have emerged as a promising novel class of anti-cancer drug targets. 
Inhibition of SIRT1 and SIRT2 induces apoptosis in cancer cells and they play 
multifaceted roles in regulating autophagy. In the present study, we found that 
salermide, a SIRT1/2-specific inhibitor or small interfering RNAs (siRNAs) to 
block SIRT1/2 expression could induce autophagy in human NSCLC cells. Moreover, 
SIRT1/2 inhibition increased the expression levels of ATF4 and DDIT4 and 
downregulated p-RPS6KB1 and p-EIF4EBP1, two downstream molecules of mTORC1. 
Moreover, ATF4 or DDIT4 knockdown attenuated salermide-induced autophagy, 
suggesting that SIRT1/2 inhibition induced autophagy through the 
ATF4-DDIT4-mTORC1 axis. Mechanistically, SIRT1/2 inhibition led to HSPA5 
acetylation and dissociation from EIF2AK3, leading to ER stress response and 
followed by upregulation of ATF4 and DDIT4, triggering autophagy. Silencing of 
the autophagic gene ATG5 in lung cancer cells resulted in increased apoptotic 
cell death induced by SIRT1/2 inhibition. Our data show that inhibition of 
SIRT1/2 induces pro-survival autophagy via acetylation of HSPA5 and subsequent 
activation of ATF4 and DDIT4 to inhibit the mTOR signaling pathway in NSCLC 
cells. These findings suggest that combinatorial treatment with SIRT1/2 
inhibitors and pharmacological autophagy inhibitors is an effective therapeutic 
strategy for cancer therapy.]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="426~486" text="small interfering RNAs (siRNAs) to  block SIRT1/2 expression" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P1" spans="383~422" text="salermide, a SIRT1/2-specific inhibitor" perturbingaction="pharmacological inhibition" />
<PERTURBING_ACTION id="P2" spans="543~561" text="SIRT1/2 inhibition" perturbingaction="pharmacological inhibition" />
<PERTURBING_ACTION id="P3" spans="704~727" text="ATF4 or DDIT4 knockdown" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P4" spans="785~803" text="SIRT1/2 inhibition" perturbingaction="pharmacological inhibition" />
<PERTURBING_ACTION id="P5" spans="876~894" text="SIRT1/2 inhibition" perturbingaction="pharmacological inhibition" />
<PERTURBING_ACTION id="P6" spans="1053~1091" text="Silencing of  the autophagic gene ATG5" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P7" spans="1168~1186" text="SIRT1/2 inhibition" perturbingaction="pharmacological inhibition" />
<PERTURBING_ACTION id="P8" spans="1207~1229" text="inhibition of  SIRT1/2" perturbingaction="pharmacological inhibition" />
<CONTEXT id="C0" spans="513~530" text="human NSCLC cells" context="transformed cells" />
<CONTEXT id="C1" spans="1095~1112" text="lung cancer cells" context="transformed cells" />
<CONTEXT id="C2" spans="1372~1384" text="NSCLC  cells" context="transformed cells" />
<PHENOTYPE id="PH0" spans="500~509" text="autophagy" phenotype="autophagy" />
<PHENOTYPE id="PH1" spans="757~766" text="autophagy" phenotype="autophagy" />
<PHENOTYPE id="PH2" spans="812~821" text="autophagy" phenotype="autophagy" />
<PHENOTYPE id="PH3" spans="1042~1051" text="autophagy" phenotype="autophagy" />
<PHENOTYPE id="PH4" spans="1135~1156" text="apoptotic  cell death" phenotype="autophagy" />
<PHENOTYPE id="PH5" spans="1251~1260" text="autophagy" phenotype="autophagy" />
<EFFECT id="E0" spans="493~499" text="induce" effect="positive" />
<EFFECT id="E1" spans="728~738" text="attenuated" effect="negative" />
<EFFECT id="E2" spans="804~811" text="induced" effect="positive" />
<EFFECT id="E3" spans="1031~1041" text="triggering" effect="positive" />
<EFFECT id="E4" spans="1125~1134" text="increased" effect="positive" />
<EFFECT id="E5" spans="1230~1237" text="induces" effect="positive" />
<EFFECT id="E6" spans="1157~1164" text="induced" effect="positive" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P1" perturbing_actionText="salermide, a SIRT1/2-specific inhibitor" contextID="C0" contextText="human NSCLC cells" effectID="E0" effectText="induce" phenotypeID="PH0" phenotypeText="autophagy" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P0" perturbing_actionText="small interfering RNAs (siRNAs) to  block SIRT1/2 expression" effectID="E0" effectText="induce" contextID="C0" contextText="human NSCLC cells" phenotypeID="PH0" phenotypeText="autophagy" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P6" perturbing_actionText="Silencing of  the autophagic gene ATG5" contextID="C1" contextText="lung cancer cells" effectID="E4" effectText="increased" phenotypeID="PH4" phenotypeText="apoptotic  cell death" />
<ENTITY_LINKING id="EN3" perturbing_actionID="P7" perturbing_actionText="SIRT1/2 inhibition" contextID="C1" contextText="lung cancer cells" effectID="E6" effectText="induced" phenotypeID="PH4" phenotypeText="apoptotic  cell death" />
<ENTITY_LINKING id="EN4" perturbing_actionID="P8" perturbing_actionText="inhibition of  SIRT1/2" effectID="E5" effectText="induces" phenotypeID="PH5" phenotypeText="autophagy" contextID="C2" contextText="NSCLC  cells" />
</TAGS>
</Genomics_ConceptTask>